Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Irazu Oncology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Irazu Oncology

Irazu Oncology

Seed

Baltimore-based medical organization pioneering superior cancer vaccine platforms for improved outcomes.

HQ
Baltimore, MD, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Irazu Oncology, founded in Baltimore, Maryland, is dedicated to pioneering advanced cancer vaccine platforms aimed at significantly improving clinical outcomes for cancer patients. The company's core mission revolves around developing a flexible, cost-effective vaccine platform with broad applications across various types of cancer. By focusing on innovative immunotherapy solutions, Irazu Oncology aims to address unmet medical needs and enhance the quality of life for cancer patients globally.

Notable figures associated with Irazu Oncology include a distinguished team of experts and advisors from the fields of oncology and immunotherapy. The organization has garnered attention for its cutting-edge research and development efforts, contributing to the evolving landscape of cancer treatment. Through its innovative vaccine platform, Irazu Oncology has made a substantial impact on the medical community, offering new hope and potential for improved patient outcomes in the fight against cancer.

Irazu Oncology - Similar Companies

Cancervax logo

Cancervax

cancervax.com

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

Istari Oncology logo

Istari Oncology

istarioncology.com

Adventris Pharmaceuticals logo

Adventris Pharmaceuticals

Oncology Honduras logo

Oncology Honduras

Oncospace logo

Oncospace

oncospace.com

OncoResponse logo

OncoResponse

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Oncosting logo

Oncosting

oncosting.com

Curevax logo

Curevax

Oncofactor logo

Oncofactor

oncofactor.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Ubivac logo

Ubivac

ubivac.com

Oncolyze logo

Oncolyze

oncolyze.com

Vivacitas Oncology logo

Vivacitas Oncology

vivaoncology.com

Irazu Oncology - Quick Facts

Who are Irazu Oncology's competitors?

Companies similar to Irazu Oncology include Cancervax, EpiVax Oncology, Istari Oncology and Adventris Pharmaceuticals.

When was Irazu Oncology founded?

Irazu Oncology was founded in 2022.

Where is Irazu Oncology's headquarters located?

Irazu Oncology's headquarters is located in Baltimore, MD, US.

When was Irazu Oncology's last funding round?

Irazu Oncology's most recent funding round was for $2.6M (USD) in December 2023.

How much has Irazu Oncology raised to-date?

As of Dec 14, 2023, Irazu Oncology has raised a total of $2.6M (USD).

How many employees does Irazu Oncology have?

Irazu Oncology has 5 employees as of Feb 5, 2024.

Irazu Oncology - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified